v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock and Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Common stock, beginning balance (in shares) at Dec. 31, 2024   64,043,799    
Stockholders' equity (deficit), beginning balance at Dec. 31, 2024 $ 365,207 $ 1,552,714 $ (1,186,672) $ (835)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units and restricted shares (in shares)   1,453,745    
Vesting of restricted stock units and restricted shares 0      
Issuance of common stock under employee stock purchase plan (in shares)   312,903    
Issuance of common stock under employee stock purchase plan 1,003 $ 1,003    
Stock-based compensation 16,406 $ 16,406    
Stock repurchases (in shares)   (1,103,601)    
Stock repurchases (5,000) $ (5,000)    
Issuance of common stock related to acquisition (in shares)   5,560,583    
Issuance of common stock related to acquisitions 31,584 $ 31,584    
Net loss (64,720)   (64,720) 0
Other comprehensive income (loss) 3,067     3,067
Common stock, ending balance (in shares) at Jun. 30, 2025   70,267,429    
Stockholders' equity (deficit), ending balance at Jun. 30, 2025 347,547 $ 1,596,707 (1,251,392) 2,232
Common stock, beginning balance (in shares) at Mar. 31, 2025   69,481,638    
Stockholders' equity (deficit), beginning balance at Mar. 31, 2025 376,811 $ 1,587,085 (1,210,414) 140
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units and restricted shares (in shares)   472,888    
Vesting of restricted stock units and restricted shares 0      
Issuance of common stock under employee stock purchase plan (in shares)   312,903    
Issuance of common stock under employee stock purchase plan 1,003 $ 1,003    
Stock-based compensation 8,619 $ 8,619    
Net loss (40,978)   (40,978)  
Other comprehensive income (loss) 2,092     2,092
Common stock, ending balance (in shares) at Jun. 30, 2025   70,267,429    
Stockholders' equity (deficit), ending balance at Jun. 30, 2025 $ 347,547 $ 1,596,707 (1,251,392) 2,232
Common stock, beginning balance (in shares) at Dec. 31, 2025 72,027,332 72,027,332    
Stockholders' equity (deficit), beginning balance at Dec. 31, 2025 $ 245,780 $ 1,608,840 (1,364,646) 1,586
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units and restricted shares (in shares)   2,358,012    
Vesting of restricted stock units and restricted shares 0      
Issuance of common stock under employee stock purchase plan (in shares)   213,148    
Issuance of common stock under employee stock purchase plan 360 $ 360    
Stock-based compensation 6,804 $ 6,804    
Net loss (151,563)   (151,563)  
Other comprehensive income (loss) $ (554)     (554)
Common stock, ending balance (in shares) at Jun. 30, 2026 74,598,492 74,598,492    
Stockholders' equity (deficit), ending balance at Jun. 30, 2026 $ 100,827 $ 1,616,004 (1,516,209) 1,032
Common stock, beginning balance (in shares) at Mar. 31, 2026   73,748,666    
Stockholders' equity (deficit), beginning balance at Mar. 31, 2026 138,145 $ 1,612,808 (1,475,672) 1,009
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units and restricted shares (in shares)   636,678    
Vesting of restricted stock units and restricted shares 0      
Issuance of common stock under employee stock purchase plan (in shares)   213,148    
Issuance of common stock under employee stock purchase plan 360 $ 360    
Stock-based compensation 2,836 $ 2,836    
Net loss (40,537)   (40,537)  
Other comprehensive income (loss) $ 23     23
Common stock, ending balance (in shares) at Jun. 30, 2026 74,598,492 74,598,492    
Stockholders' equity (deficit), ending balance at Jun. 30, 2026 $ 100,827 $ 1,616,004 $ (1,516,209) $ 1,032